The novel diagnostic marker in low-LVEF heart failure patients

8Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE: The structural and compositional changes in the myocardium seem to have a major role in the development of heart failure (HF).Imbalance between production and degradation in extracellular collagen results in increase of collagen synthesis biomarkers in the circulation as the carboxy-terminal propeptide of type I procollagen (PIP). Here we aimed to determine role of PIP in the diagnosis of chronic HF. MATERIAL AND METHODS: 87 patients with HF group and 80 healthy subjects were enrolled into the study. Echocardiographic examination was performed.At the beginning of the study, serum B type natriuretic peptide (BNP), PIP, high sensitive C-reactive protein (hs-CRP) were measured . The subjects were followed for one year then after. RESULTS:Average PIP value of HF group was signifi cantly higher than that of the control group (p < 0.001). Both hs-CRP and BNP values were well correlated to PIP values (p < 0.001). In the HF group, PIP value of patients who died at the end of one year was similar to that of patients who survived at the end of fi rst year. CONCLUSION: PIP may not mirror acute events in follow-up of chronic heart failure but it is a very benefi cial biomarker in diagnosis of low-LVEF heart failure with high sensitivity and specifi city.

Author supplied keywords

Cite

CITATION STYLE

APA

Demir, S., Ede, H., Kaplan, M., Yavuz, F., Yucel, C., & Kurt, I. H. (2018). The novel diagnostic marker in low-LVEF heart failure patients. Bratislava Medical Journal, 119(7), 421–424. https://doi.org/10.4149/BLL_2018_076

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free